bn:00046690n
Noun Concept
Categories: Drugboxes which contain changes to verified fields, Janssen Biotech, World Health Organization essential medicines, Drugs that are a monoclonal antibody, Schering-Plough brands
EN
infliximab  Remicade  ATC code L04AB02  ATCvet code QL04AB02  Avsola
EN
An anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis WordNet 3.0
Definitions
Relations
Sources
EN
An anti-TNF compound (trade name Remicade) consisting of an antibody directed against TNF; it is given intravenously at one-month to three-month intervals; used in treatment of regional enteritis and rheumatoid arthritis WordNet 3.0 & Open English WordNet
Infliximab, a chimeric monoclonal antibody, sold under the brand name Remicade among others, is a medication used to treat a number of autoimmune diseases. Wikipedia
Pharmaceutical drug Wikidata
WordNet 3.0 & Open English WordNet
Wikipedia
Wikidata
Wikidata Alias